Considerations about COVID-19 vaccines in pregnant and nursing mothers

Abstract

Currently, there are vaccines with proven efficacy and safety in the mother-child binomial, such as the anti-influenza, anti-diphtheria, anti-tetanus, and acellular anti-pertussis vaccines. The most effective method in the control of epidemics and pandemics is vaccination, especially in priority groups that could have serious and complicated manifestations of the disease such as pregnant women. Currently, there are candidates for COVID-19 vaccines with different platforms: mRNA, non-replicative adenovirus vectors, DNA, inactivated whole virus, and protein subunits, among others. The Health Organization (WHO), the Centers for Disease Control (CDC), the American College of Obstetrics and Gynecology of the United States, and the National Academy of Medicine of Venezuela have pronounced on the subject and agree that pregnant and lactating women should be included in the priority group in the immunization plans of the countries, with the COVID-19 vaccines approved in that population group.